Literature DB >> 4584345

Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.

R P Messner, F D Lindström, R C Williams.   

Abstract

Peripheral blood lymphocytes from 23 patients with active systemic lupus erythematosus (SLE) were serially studied. Changes in bone marrow-derived lymphocytes (B cells), as measured by surface Ig receptors and C3 receptors, and in thymus-derived cells (T cells) measured by rabbit T-cell-specific antiserum and E-binding techniques, were correlated with fluctuations in clinical disease activity and treatment. In normal controls B- and T-cell percentages remained relatively stable, although the situation in SLE was much more labile. A relative and absolute decrease in T lymphocytes and cells bearing a receptor for C3 was found in active lupus. Absolute numbers of cells bearing surface Ig were decreased to a lesser extent, whereas the proportion of these cells was increased. It is postulated that the increase in autoantibody formation and diminished delayed hypersensitivity seen in systemic lupus may be due to a loss of T-lymphocyte function.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4584345      PMCID: PMC302579          DOI: 10.1172/JCI107503

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Specific in vitro cytotoxicity of thymus-derived lymphocytes sensitized to alloantigens.

Authors:  J C Cerottini; A A Nordin; K T Brunner
Journal:  Nature       Date:  1970-12-26       Impact factor: 49.962

2.  Cell interactions in the induction of tolerance: the role of thymic lymphocytes.

Authors:  R K Gershon; K Kondo
Journal:  Immunology       Date:  1970-05       Impact factor: 7.397

3.  Cytotoxins in disease. Autocytotoxins in lupus.

Authors:  P I Terasaki; V D Mottironi; E V Barnett
Journal:  N Engl J Med       Date:  1970-10-01       Impact factor: 91.245

4.  Theta isoantigen as a marker of thymus-derived lymphocytes in mice.

Authors:  M Raff
Journal:  Nature       Date:  1969-10-25       Impact factor: 49.962

5.  Lymphocyte cytotoxic antibodies in systemic lupus erythematosus.

Authors:  K K Mittal; R D Rossen; J T Sharp; M D Lidsky; W T Butler
Journal:  Nature       Date:  1970-03-28       Impact factor: 49.962

6.  Changes in lymphoid populations of ageing CBA and NZB mice.

Authors:  M M Zatz; R C Mellors; E M Lance
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

7.  Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the main source of lymphocytes with detectable surface-bound immunoglobulin.

Authors:  E R Unanue; H M Grey; E Rabellino; P Campbell; J Schmidtke
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

8.  Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation.

Authors:  E Rabellino; S Colon; H M Grey; E R Unanue
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

9.  Immunoglobulin spots on the surface of rabbit lymphocytes.

Authors:  B Pernis; L Forni; L Amante
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

10.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

View more
  48 in total

1.  T and B lymphocytes in patients with chronic renal disease on hemodialysis.

Authors:  M M Reddy; K O Goh; R V Cestero
Journal:  Experientia       Date:  1975-08-15

2.  Antibodies for T lymphocytes in systemic lupus erythematosus.

Authors:  G Michlmayr; C Pathouli; C Huber; H Huber
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

3.  Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus.

Authors:  R J DeHoratius; R P Messner
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

4.  Lymphocyte subpopulations in chronic liver disease.

Authors:  I G McFarlane; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

5.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

6.  Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease.

Authors:  G Husby; R G Strickland; J L Caldwell; R C Williams
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

7.  Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.

Authors:  W Glinski; M E Gershwin; A D Steinberg
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

8.  Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions.

Authors:  C Morimoto; E L Reinherz; J A Distaso; A D Steinberg; S F Schlossman
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

9.  The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosus.

Authors:  P S Mach; M Kharouby; F Lutcher; J L Olivier; N Bazely; M Dougados; B Amor
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

10.  Antibody-dependent and phytohaemagglutinin-induced lymphocyte cytotoxicity in systemic lupus erythematosus.

Authors:  J K Wright; P Hughes; K Gelsthorpe; A M Ward; N R Rowell
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.